Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-03-001426
Filing Date
2003-11-14
Accepted
2003-11-14 16:03:56
Documents
4
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 6-K REPORT OF FOREIGN ISSUER sdc556.htm 6-K 255494
3 GRAPHIC nymox.gif GRAPHIC 3971
4 COMMON STOCK PRICATE PURCHASE AGREEMENT sdc556a.htm EX-10.1 108366
6 GRAPHIC foley.gif GRAPHIC 2517
  Complete submission text file 0000897069-03-001426.txt   372244
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 031004675
SIC: 2835 In Vitro & In Vivo Diagnostic Substances